Neurotech (ASX:NTI) shares went on a 30%-plus romp this morning after the US Food and Drug Administration (FDA) granted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results